Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Sang Taek Jung, PhD
Associate Professor at Seoul National University
Speaker

Profile

Dr. Sang Taek Jung is a professor in the Department of Chemical and Biological Engineering at Seoul National University. His research explores the fundamental interactions among antibodies, immune receptors, and soluble ligands by integrating protein science, protein evolution, and engineering principles. His group develops innovative platforms for antibody discovery, engineers therapeutic proteins for enhanced efficacy, safety, and serum persistence, and expands antibody-based therapeutic modalities through bispecific antibodies, antibody–drug conjugates, and other next-generation immunotherapeutics. Dr. Jung received his B.S. and M.S. degrees from Seoul National University. Before pursuing his doctoral studies, he spent 5.5 years in the biopharmaceutical industry at Green Cross Corporation and Samyang Genex. He subsequently earned his Ph.D. in Chemical Engineering from the University of Texas at Austin under the supervision of Professor George Georgiou and conducted postdoctoral research with Professor Frances H. Arnold at Caltech. Before joining Seoul National University in 2024, he served on the faculties of Kookmin University and subsequently Korea University. He has published more than 75 peer-reviewed articles and is an inventor on more than 300 domestic and international patent applications and granted patents. Since 2018, 13 technologies have been transferred to 11 companies, with an aggregate deal value exceeding US$90 million. His contributions to technology commercialization were recognized with a Ministerial Commendation from the Korean Ministry of Science and ICT.

Agenda Sessions

  • Expanding the Fc Functional Spectrum: A Diverse Repertoire of Novel Fc Variants for Enhanced Potency, Complete Effector Silencing, Extended Persistence, and Accelerated Pathogenic IgG Clearance

    4:15pm